Experimental and Clinical Studied for process of gastric carcinogenesis

胃癌发生过程的实验与临床研究

基本信息

  • 批准号:
    12671215
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

The process of gastric carcinogenesis concerning Helicobacter pylori ( Hp ) was studied, and following results were obtained.1. In Mongolian gerbil ( MG ) model Hp and chemical carcinogen induce several phenotype of gastric cancer, but intestinal metaplasia may be a direct precursor only in a subset of the intestinal-type tumors.2. In the relationship between Hp and gastric carcinogenesis, Hp is a promoter rather than an initiator, and other environmental factors ( the timing of carcinogen administration ) play important roles.3. Hp infection plus duodenogastric reflux increase cell proliferation in the gastric mucosa in MG model.4. Hp eradication diminishes enhancing effect of Hp infection on glandular stomach carcinogenesis in MGs. Hp eradication may be useful as a prevention approach against stomach cancer.5. In the early stage of Hp infection, accentuation of intramucosal PGE2 and hypersecretion of mucin from gland mucus cells have a protective effect against gastric mucosal injury induced by necrotizing agents.6. As results, the expression level of a 4GnT mRNA tended to be increased in the pyloric mucosa with Hp infection, suggesting that Hp infection enhances the biosynthesis of gland mucous cell-type mucin.
本研究对幽门螺杆菌(Helicobacter pylori,Hp)在胃癌发生过程中的作用进行了研究,取得了以下结果.在蒙古沙鼠(MG)模型中,Hp和化学致癌物可诱发多种胃癌表型,但肠上皮化生可能仅是一个亚组的胃癌的直接前体.在Hp与胃癌发生的关系中,Hp是一种促进剂而非引发剂,其他环境因素(致癌剂给药时机)也起重要作用. Hp感染+胃反流可促进MG模型胃粘膜细胞增殖.根除Hp可降低Hp感染对MG腺胃癌发生的促进作用。根除Hp可能是预防胃癌的有效方法。在Hp感染早期,胃粘膜内PGE2的升高和腺粘液细胞粘蛋白的分泌增加对坏死因子引起的胃粘膜损伤具有保护作用.结果表明,幽门螺杆菌感染时幽门粘膜中α 4GnT mRNA的表达水平有增加的趋势,提示幽门螺杆菌感染促进了腺粘液细胞型粘蛋白的生物合成。

项目成果

期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Maruta F,Sugiyama A et al: "Role of nitrosourea in the induction of intestinal metaplasia and gastric carcinoma in Mongolian gerbils infected with Helicobacter pylori"Scandinavian Journal of gastroenterology. (In press). (2001)
Maruta F,Sugiyama A等人:“亚硝基脲在感染幽门螺杆菌的蒙古沙鼠中诱导肠上皮化生和胃癌中的作用”斯堪的纳维亚胃肠病学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Marta F, Sugiyama A et al.: "Timing of N-methyl-N-nitrosourea administration effects gastric carcinogenesis in Mongolian gerbils infected with Helicobacter pylori"Cancer Letter. 160. 99-105 (2000)
Marta F、Sugiyama A 等人:“N-甲基-N-亚硝基脲给药时机影响感染幽门螺杆菌的蒙古沙鼠的胃癌发生”《癌症信》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
丸田福門,杉山敦 ほか: "Helicobacter pylori感染スナネズミにおける胃発癌"消化器科. 30. 16-22 (2000)
Fukumon Maruta,Atsushi Sugiyama 等:“感染幽门螺杆菌的沙鼠的胃癌发生”,胃肠病学系,30. 16-22 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Maruta,F., Ota,H., Genta,M., Sugiyama,A., Tatematsu,M., Katsuyama,T., Kawasaki,S.: "Role of N-methyl-N-nitrosurea in the induction of intestinal metaplasia and gastric adenocarcinoma in Mongolian gerbils infected with Helicobacter pylori"Scand J Gastroent
Maruta,F.,Ota,H.,Genta,M.,Sugiyama,A.,Tatematsu,M.,Katsuyama,T.,川崎,S.:“N-甲基-N-亚硝基脲在诱导肠道中的作用
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUGIYAMA Atsushi其他文献

SUGIYAMA Atsushi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUGIYAMA Atsushi', 18)}}的其他基金

Effects of EP4 receptor agonist on the left ventricular diastolic function, and analysis of its mechanism
EP4受体激动剂对左心室舒张功能的影响及其机制分析
  • 批准号:
    16K08559
  • 财政年份:
    2016
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of onset mechanisms of a sphingosine 1-phosphate receptor modulator fingolomod-induced atrioventricular conduction block
1-磷酸鞘氨醇受体调节剂芬戈洛莫德引起房室传导阻滞的发病机制分析
  • 批准号:
    25460344
  • 财政年份:
    2013
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of therapeutic target molecules againstatrial fibrillation: Use of the canine persistent atrial fibrillation model
抗房颤治疗靶分子的鉴定:犬持续性房颤模型的使用
  • 批准号:
    22590237
  • 财政年份:
    2010
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Search of upstream drugs for treatment of atrial fibrillation using a new canine atrial fibrillation model
利用新的犬房颤模型寻找治疗房颤的上游药物
  • 批准号:
    17590216
  • 财政年份:
    2005
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dangerous QT prolongation can be assayed by using the chronic atrioventricular block dog
可以使用慢性房室传导阻滞犬来检测危险的 QT 延长
  • 批准号:
    15590222
  • 财政年份:
    2003
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Host-response in gastric mucosa in fected with Helicobacter pylori
幽门螺杆菌感染胃粘膜的宿主反应
  • 批准号:
    14571187
  • 财政年份:
    2002
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

研发纳米金材料改良免疫探测器用于定量分析污水中幽门螺旋杆菌(Helicobacter pylori, Hp)的新型流行病学研究
  • 批准号:
    LQ22B050004
  • 批准年份:
    2021
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MODEL PATHOGEN
使用幽门螺杆菌作为模型病原体,对抗胃肠粘膜病原体的下一代疫苗
  • 批准号:
    10078052
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    EU-Funded
Investigation of ability of Helicobacter pylori to adhere to infected dentin and its association with failure of eradication
幽门螺杆菌粘附于感染牙本质的能力及其与根除失败的关系的研究
  • 批准号:
    23K16237
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Interactions Between the Microbiota and Helicobacter pylori in Gastric Carcinogenesis
微生物群与幽门螺杆菌在胃癌发生中的相互作用
  • 批准号:
    10709135
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Polyamine Dysregulation in the Gastric Epithelium during Helicobacter pylori Infection and its Impact on Gastric Carcinogenesis
幽门螺杆菌感染期间胃上皮多胺失调及其对胃癌发生的影响
  • 批准号:
    10604957
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
The role of Hippo signalling effector YAP during Helicobacter pylori infection
Hippo信号效应子YAP在幽门螺杆菌感染中的作用
  • 批准号:
    500441
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Studentship Programs
Investigating gastric inflammation and preneoplastic progression driven by Helicobacter pylori infection
研究幽门螺杆菌感染驱动的胃部炎症和癌前进展
  • 批准号:
    10661588
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
N-terminal acylation and sorting of Helicobacter pylori lipoproteins and their role in host response to infection
幽门螺杆菌脂蛋白的 N 末端酰化和分选及其在宿主感染反应中的作用
  • 批准号:
    10584620
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Biophysical determinants of chemotaxis in Helicobacter pylori
幽门螺杆菌趋化性的生物物理决定因素
  • 批准号:
    10556394
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Mechanisms of antimicrobial resistance in Helicobacter pylori
幽门螺杆菌耐药机制
  • 批准号:
    2746397
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Studentship
Effect of TRPML1 inhibition by Helicobacter pylori vacuolating cytotoxin on mitochondrial dynamics and function
幽门螺杆菌空泡细胞毒素抑制 TRPML1 对线粒体动力学和功能的影响
  • 批准号:
    485981
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了